company background image
1066 logo

Shandong Weigao Group Medical Polymer Informe acción SEHK:1066

Último precio

HK$4.57

Capitalización de mercado

HK$20.9b

7D

-3.6%

1Y

-39.1%

Actualizada

23 Dec, 2024

Datos

Finanzas de la empresa +

Shandong Weigao Group Medical Polymer Company Limited

Informe acción SEHK:1066

Capitalización de mercado: HK$20.9b

Resumen de acción 1066

Shandong Weigao Group Medical Polymer Company Limited se dedica a la investigación y desarrollo, producción, venta al por mayor y venta de productos sanitarios en la República Popular China. Saber más

Análisis fundamental de 1066
Puntuación del snowflake
Valoración6/6
Crecimiento futuro1/6
Rendimiento pasado2/6
Salud financiera6/6
Dividendos4/6

Recompensas

Cotiza un 58.4% por debajo de nuestra estimación de su valor justo

Se prevé un crecimiento anual de los beneficios de 10.13%

Cotiza a buen valor en comparación con empresas similares e industria

Los analistas coinciden en que el precio de las acciones subirá un 43.2%

Análisis de riesgos

Historial de dividendos inestable


Mis notas

Captura tus ideas, enlaces y narrativas de la empresa

Competidores de Shandong Weigao Group Medical Polymer Company Limited

Shanghai Conant Optical

SEHK:2276

HK$9.4b

Kangji Medical Holdings

SEHK:9997

HK$7.8b

OrbusNeich Medical Group Holdings

SEHK:6929

HK$3.3b

Shanghai INT Medical Instruments

SEHK:1501

HK$4.8b

Historial de precios y rendimiento

Resumen de las cotizaciones máximas, mínimas y variaciones del Shandong Weigao Group Medical Polymer
Precios históricos de las acciones
Precio actual de la acciónHK$4.57
Máximo en las últimas 52 semanasHK$7.70
Mínimo de 52 semanasHK$3.60
Beta0.46
Cambio en 1 mes3.86%
Variación en 3 meses-4.19%
Cambio de 1 año-39.07%
Variación en 3 años-51.33%
Variación en 5 años-48.94%
Variación desde la OPV2,549.28%

Noticias y actualizaciones recientes

Is Shandong Weigao Group Medical Polymer (HKG:1066) A Risky Investment?

Nov 26
Is Shandong Weigao Group Medical Polymer (HKG:1066) A Risky Investment?

Be Wary Of Shandong Weigao Group Medical Polymer (HKG:1066) And Its Returns On Capital

Nov 04
Be Wary Of Shandong Weigao Group Medical Polymer (HKG:1066) And Its Returns On Capital

Recent updates

Is Shandong Weigao Group Medical Polymer (HKG:1066) A Risky Investment?

Nov 26
Is Shandong Weigao Group Medical Polymer (HKG:1066) A Risky Investment?

Be Wary Of Shandong Weigao Group Medical Polymer (HKG:1066) And Its Returns On Capital

Nov 04
Be Wary Of Shandong Weigao Group Medical Polymer (HKG:1066) And Its Returns On Capital

Analysts Have Been Trimming Their Shandong Weigao Group Medical Polymer Company Limited (HKG:1066) Price Target After Its Latest Report

Sep 24
Analysts Have Been Trimming Their Shandong Weigao Group Medical Polymer Company Limited (HKG:1066) Price Target After Its Latest Report

Shandong Weigao Group Medical Polymer Company Limited (HKG:1066) Just Reported, And Analysts Assigned A HK$6.74 Price Target

Aug 30
Shandong Weigao Group Medical Polymer Company Limited (HKG:1066) Just Reported, And Analysts Assigned A HK$6.74 Price Target

Shandong Weigao Group Medical Polymer Company Limited's (HKG:1066) 27% Share Price Plunge Could Signal Some Risk

Jun 25
Shandong Weigao Group Medical Polymer Company Limited's (HKG:1066) 27% Share Price Plunge Could Signal Some Risk

Here's What To Make Of Shandong Weigao Group Medical Polymer's (HKG:1066) Decelerating Rates Of Return

Jun 23
Here's What To Make Of Shandong Weigao Group Medical Polymer's (HKG:1066) Decelerating Rates Of Return

Shandong Weigao Group Medical Polymer's (HKG:1066) Shareholders Will Receive A Bigger Dividend Than Last Year

May 31
Shandong Weigao Group Medical Polymer's (HKG:1066) Shareholders Will Receive A Bigger Dividend Than Last Year

We Think Shandong Weigao Group Medical Polymer Company Limited's (HKG:1066) CEO Compensation Package Needs To Be Put Under A Microscope

May 22
We Think Shandong Weigao Group Medical Polymer Company Limited's (HKG:1066) CEO Compensation Package Needs To Be Put Under A Microscope

Earnings Not Telling The Story For Shandong Weigao Group Medical Polymer Company Limited (HKG:1066)

Apr 23
Earnings Not Telling The Story For Shandong Weigao Group Medical Polymer Company Limited (HKG:1066)

Analysts Have Lowered Expectations For Shandong Weigao Group Medical Polymer Company Limited (HKG:1066) After Its Latest Results

Mar 28
Analysts Have Lowered Expectations For Shandong Weigao Group Medical Polymer Company Limited (HKG:1066) After Its Latest Results

Shandong Weigao Group Medical Polymer Company Limited's (HKG:1066) Shares May Have Run Too Fast Too Soon

Jan 09
Shandong Weigao Group Medical Polymer Company Limited's (HKG:1066) Shares May Have Run Too Fast Too Soon

Returns On Capital Are Showing Encouraging Signs At Shandong Weigao Group Medical Polymer (HKG:1066)

Dec 22
Returns On Capital Are Showing Encouraging Signs At Shandong Weigao Group Medical Polymer (HKG:1066)

Are Investors Undervaluing Shandong Weigao Group Medical Polymer Company Limited (HKG:1066) By 44%?

Nov 10
Are Investors Undervaluing Shandong Weigao Group Medical Polymer Company Limited (HKG:1066) By 44%?

Does Shandong Weigao Group Medical Polymer (HKG:1066) Have A Healthy Balance Sheet?

Oct 05
Does Shandong Weigao Group Medical Polymer (HKG:1066) Have A Healthy Balance Sheet?

Return Trends At Shandong Weigao Group Medical Polymer (HKG:1066) Aren't Appealing

Aug 01
Return Trends At Shandong Weigao Group Medical Polymer (HKG:1066) Aren't Appealing

Is Shandong Weigao Group Medical Polymer Company Limited (HKG:1066) Trading At A 28% Discount?

Jul 19
Is Shandong Weigao Group Medical Polymer Company Limited (HKG:1066) Trading At A 28% Discount?

Shandong Weigao Group Medical Polymer (HKG:1066) Ticks All The Boxes When It Comes To Earnings Growth

Jun 22
Shandong Weigao Group Medical Polymer (HKG:1066) Ticks All The Boxes When It Comes To Earnings Growth

Is Shandong Weigao Group Medical Polymer (HKG:1066) Using Too Much Debt?

Jun 09
Is Shandong Weigao Group Medical Polymer (HKG:1066) Using Too Much Debt?

The Returns At Shandong Weigao Group Medical Polymer (HKG:1066) Aren't Growing

Apr 27
The Returns At Shandong Weigao Group Medical Polymer (HKG:1066) Aren't Growing

Shandong Weigao Group Medical Polymer (HKG:1066) Ticks All The Boxes When It Comes To Earnings Growth

Mar 17
Shandong Weigao Group Medical Polymer (HKG:1066) Ticks All The Boxes When It Comes To Earnings Growth

A Look At The Intrinsic Value Of Shandong Weigao Group Medical Polymer Company Limited (HKG:1066)

Feb 27
A Look At The Intrinsic Value Of Shandong Weigao Group Medical Polymer Company Limited (HKG:1066)

Returns On Capital At Shandong Weigao Group Medical Polymer (HKG:1066) Have Hit The Brakes

Jan 18
Returns On Capital At Shandong Weigao Group Medical Polymer (HKG:1066) Have Hit The Brakes

Does Shandong Weigao Group Medical Polymer (HKG:1066) Have A Healthy Balance Sheet?

Dec 12
Does Shandong Weigao Group Medical Polymer (HKG:1066) Have A Healthy Balance Sheet?

Shandong Weigao Group Medical Polymer Company Limited (HKG:1066) Shares Could Be 21% Below Their Intrinsic Value Estimate

Nov 29
Shandong Weigao Group Medical Polymer Company Limited (HKG:1066) Shares Could Be 21% Below Their Intrinsic Value Estimate

Here's Why We Think Shandong Weigao Group Medical Polymer (HKG:1066) Might Deserve Your Attention Today

Nov 14
Here's Why We Think Shandong Weigao Group Medical Polymer (HKG:1066) Might Deserve Your Attention Today

Shandong Weigao Group Medical Polymer (HKG:1066) Is Paying Out A Larger Dividend Than Last Year

Oct 03
Shandong Weigao Group Medical Polymer (HKG:1066) Is Paying Out A Larger Dividend Than Last Year

The Returns At Shandong Weigao Group Medical Polymer (HKG:1066) Aren't Growing

Sep 21
The Returns At Shandong Weigao Group Medical Polymer (HKG:1066) Aren't Growing

Shandong Weigao Group Medical Polymer (HKG:1066) Could Easily Take On More Debt

Sep 05
Shandong Weigao Group Medical Polymer (HKG:1066) Could Easily Take On More Debt

Shandong Weigao Group Medical Polymer Company Limited's (HKG:1066) Intrinsic Value Is Potentially 27% Above Its Share Price

Aug 23
Shandong Weigao Group Medical Polymer Company Limited's (HKG:1066) Intrinsic Value Is Potentially 27% Above Its Share Price

Here's Why Shandong Weigao Group Medical Polymer (HKG:1066) Has Caught The Eye Of Investors

Aug 08
Here's Why Shandong Weigao Group Medical Polymer (HKG:1066) Has Caught The Eye Of Investors

There's Been No Shortage Of Growth Recently For Shandong Weigao Group Medical Polymer's (HKG:1066) Returns On Capital

Jun 22
There's Been No Shortage Of Growth Recently For Shandong Weigao Group Medical Polymer's (HKG:1066) Returns On Capital

Shandong Weigao Group Medical Polymer (HKG:1066) Will Pay A Smaller Dividend Than Last Year

Jun 08
Shandong Weigao Group Medical Polymer (HKG:1066) Will Pay A Smaller Dividend Than Last Year

An Intrinsic Calculation For Shandong Weigao Group Medical Polymer Company Limited (HKG:1066) Suggests It's 27% Undervalued

May 16
An Intrinsic Calculation For Shandong Weigao Group Medical Polymer Company Limited (HKG:1066) Suggests It's 27% Undervalued

Is Shandong Weigao Group Medical Polymer (HKG:1066) A Risky Investment?

May 03
Is Shandong Weigao Group Medical Polymer (HKG:1066) A Risky Investment?

Shandong Weigao Group Medical Polymer's (HKG:1066) Returns On Capital Are Heading Higher

Mar 17
Shandong Weigao Group Medical Polymer's (HKG:1066) Returns On Capital Are Heading Higher

Is There An Opportunity With Shandong Weigao Group Medical Polymer Company Limited's (HKG:1066) 42% Undervaluation?

Jan 28
Is There An Opportunity With Shandong Weigao Group Medical Polymer Company Limited's (HKG:1066) 42% Undervaluation?

Does Shandong Weigao Group Medical Polymer (HKG:1066) Deserve A Spot On Your Watchlist?

Jan 13
Does Shandong Weigao Group Medical Polymer (HKG:1066) Deserve A Spot On Your Watchlist?

Returns Are Gaining Momentum At Shandong Weigao Group Medical Polymer (HKG:1066)

Dec 17
Returns Are Gaining Momentum At Shandong Weigao Group Medical Polymer (HKG:1066)

Shandong Weigao Group Medical Polymer (HKG:1066) Seems To Use Debt Rather Sparingly

Dec 05
Shandong Weigao Group Medical Polymer (HKG:1066) Seems To Use Debt Rather Sparingly

An Intrinsic Calculation For Shandong Weigao Group Medical Polymer Company Limited (HKG:1066) Suggests It's 32% Undervalued

Oct 18
An Intrinsic Calculation For Shandong Weigao Group Medical Polymer Company Limited (HKG:1066) Suggests It's 32% Undervalued

Do Shandong Weigao Group Medical Polymer's (HKG:1066) Earnings Warrant Your Attention?

Oct 06
Do Shandong Weigao Group Medical Polymer's (HKG:1066) Earnings Warrant Your Attention?

Rentabilidad de los accionistas

1066HK Medical EquipmentMercado HK
7D-3.6%-1.6%-0.5%
1Y-39.1%-27.9%19.9%

Rentabilidad vs. Industria: Los resultados de 1066 fueron inferiores a los de la industria Hong Kong Medical Equipment, que obtuvo un rendimiento del -27.9% el año pasado.

Rentabilidad vs. Mercado: 1066 obtuvo unos resultados inferiores a los del mercado Hong Kong, que fueron del 19.9% el año pasado.

Volatilidad de los precios

Is 1066's price volatile compared to industry and market?
1066 volatility
1066 Average Weekly Movement7.3%
Medical Equipment Industry Average Movement9.0%
Market Average Movement8.8%
10% most volatile stocks in HK Market18.6%
10% least volatile stocks in HK Market4.1%

Precio estable de las acciones: 1066 no ha tenido una volatilidad de precios significativa en los últimos 3 meses.

Volatilidad a lo largo del tiempo: La volatilidad semanal de 1066 (7%) se ha mantenido estable durante el año pasado.

Acerca de la empresa

FundadaEmpleadosCEOPágina web
200012,606Rinan Congwww.weigaogroup.com

Shandong Weigao Group Medical Polymer Company Limited se dedica a la investigación y el desarrollo, la producción, la venta al por mayor y la venta de dispositivos médicos en la República Popular China. Opera a través de los segmentos de productos de dispositivos médicos, productos ortopédicos, productos intervencionistas, productos de envasado farmacéutico, productos para el tratamiento de la sangre y otros. La empresa ofrece consumibles y materiales médicos de un solo uso, incluidos equipos de infusión, jeringuillas, bolsas de sangre y segregadores de componentes sanguíneos consumibles, productos para la toma de muestras de sangre, jeringuillas precargadas para medicamentos preenvasados y agujas médicas que incluyen principalmente agujas intravenosas, agujas para jeringuillas, agujas para catéteres intravenosos, agujas para la toma de muestras de sangre y agujas irregulares; materiales e instrumentos ortopédicos, incluidos productos traumatológicos de placas y tornillos de acero, implantes espinales y articulaciones artificiales; y consumibles y equipos de purificación sanguínea, incluidas agujas de punción, circuitos sanguíneos extracorpóreos para conjuntos de purificación sanguínea, dializadores y consumibles relacionados.

Resumen de fundamentos de Shandong Weigao Group Medical Polymer Company Limited

¿Cómo se comparan los beneficios e ingresos de Shandong Weigao Group Medical Polymer con su capitalización de mercado?
Estadísticas fundamentales de 1066
Capitalización bursátilHK$20.89b
Beneficios(TTM)HK$2.03b
Ingresos (TTM)HK$13.80b

10.3x

Ratio precio-beneficio (PE)

1.5x

Ratio precio-ventas (PS)

¿Está 1066 sobrevalorada?

Ver valor justo y análisis de valoración

Beneficios e Ingresos

Estadísticas clave de rentabilidad del último informe de resultados (TTM)
Cuenta de resultados (TTM) de 1066
IngresosCN¥12.97b
Coste de los ingresosCN¥6.52b
Beneficio brutoCN¥6.44b
Otros gastosCN¥4.53b
BeneficiosCN¥1.91b

Últimos beneficios comunicados

Jun 30, 2024

Próxima fecha de beneficios

n/a

Beneficios por acción (BPA)0.42
Margen bruto49.69%
Margen de beneficio neto14.74%
Ratio deuda/patrimonio16.3%

¿Cómo se ha desempeñado 1066 a largo plazo?

Ver rendimiento histórico y comparativa

Dividendos

3.9%

Rentabilidad actual por dividendo

44%

Ratio de pagos

Análisis de la empresa y estado de los datos financieros

DatosÚltima actualización (huso horario UTC)
Análisis de la empresa2024/12/23 22:49
Precio de las acciones al final del día2024/12/23 00:00
Beneficios2024/06/30
Ingresos anuales2023/12/31

Fuentes de datos

Los datos utilizados en nuestro análisis de empresas proceden de S&P Global Market Intelligence LLC. Los siguientes datos se utilizan en nuestro modelo de análisis para generar este informe. Los datos están normalizados, lo que puede introducir un retraso desde que la fuente está disponible.

PaqueteDatosMarco temporalEjemplo Fuente EE.UU. *
Finanzas de la empresa10 años
  • Cuenta de resultados
  • Estado de tesorería
  • Balance
Estimaciones del consenso de analistas+3 años
  • Previsiones financieras
  • Objetivos de precios de los analistas
Precios de mercado30 años
  • Precios de las acciones
  • Dividendos, escisiones y acciones
Propiedad10 años
  • Accionistas principales
  • Información privilegiada
Gestión10 años
  • Equipo directivo
  • Consejo de Administración
Principales avances10 años
  • Anuncios de empresas

* ejemplo para los valores estadounidenses, para los no estadounidenses se utilizan formularios y fuentes normativas equivalentes.

A menos que se especifique lo contrario, todos los datos financieros se basan en un periodo anual, pero se actualizan trimestralmente. Esto se conoce como datos de los últimos doce meses (TTM) o de los últimos doce meses (LTM). Obtenga más información aquí.

Modelo de análisis y copo de nieve

Los detalles del modelo de análisis utilizado para generar este informe están disponibles en nuestra página de Github, también tenemos guías sobre cómo utilizar nuestros informes y tutoriales en Youtube.

Conozca al equipo de talla mundial que diseñó y construyó el modelo de análisis Simply Wall St.

Métricas industriales y sectoriales

Simply Wall St calcula cada 6 horas nuestras métricas sectoriales y de sección. Los detalles de nuestro proceso están disponibles en .

Fuentes analistas

Shandong Weigao Group Medical Polymer Company Limited está cubierta por 36 analistas. 7 de esos analistas presentaron las estimaciones de ingresos o ganancias utilizadas como datos para nuestro informe. Las estimaciones de los analistas se actualizan a lo largo del día.

AnalistaInstitución
Jason MannBarclays
Derrick SunBNP Paribas Securities (Asia)
Feng Qiang SunBOCOM International Securities Limited